Acitretin

From Wikipedia, the free encyclopedia

Template:Short description

Page Module:Message box/ambox.css has no content.

Template:DMCA Template:Short description Page Template:Infobox drug/styles.css has no content.

Page Module:Infobox/styles.css has no content.

Acitretin
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Clinical data
Trade namesSoriatane, Neotigason
AHFS/Drugs.comMonograph
MedlinePlusa601010
Pregnancy
category		Page Template:Plainlist/styles.css has no content.
  • AU: X (High risk)
Routes of
administration		By mouth
ATC codePage Template:Plainlist/styles.css has no content.
Legal status
Legal statusPage Template:Plainlist/styles.css has no content.
Pharmacokinetic data
Bioavailability60%
Protein binding>99.9%
MetabolismLiver
Elimination half-life49 hours
ExcretionFaeces & urine
Identifiers
  • (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
CAS NumberPage Template:Plainlist/styles.css has no content.
PubChem CIDPage Template:Plainlist/styles.css has no content.
PubChem SIDPage Template:Plainlist/styles.css has no content.
IUPHAR/BPSPage Template:Plainlist/styles.css has no content.
DrugBankPage Template:Plainlist/styles.css has no content.
ChemSpiderPage Template:Plainlist/styles.css has no content.
UNIIPage Template:Plainlist/styles.css has no content.
KEGGPage Template:Plainlist/styles.css has no content.
ChEBIPage Template:Plainlist/styles.css has no content.
ChEMBLPage Template:Plainlist/styles.css has no content.
NIAID ChemDBPage Template:Plainlist/styles.css has no content.
PDB ligandPage Template:Plainlist/styles.css has no content.
CompTox Dashboard (EPA)Page Template:Plainlist/styles.css has no content.
Chemical and physical data
FormulaC21H26O3
Molar mass326.436 g·mol−1
3D model (JSmol)Page Template:Plainlist/styles.css has no content.
  • O=C(O)\C=C(\C=C\C=C(\C=C\c1c(cc(OC)c(c1C)C)C)C)C
  • InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+ checkY
  • Key:IHUNBGSDBOWDMA-AQFIFDHZSA-N checkY
Data page
Template:Infobox drug/data page link
Page Template:Nobold/styles.css has no content.  (verify)

Acitretin, sold under the brand names Neotigason[1] and Soriatane,[4] is a second-generation retinoid. It is taken orally, and is typically used for psoriasis.[5] It was approved for medical use in the United States in 1996.[6]

Acitretin is an oral retinoid used in the treatment of severe resistant psoriasis. Because of the potential for problems and severe side effects it is generally used in only very severe cases of psoriasis that have been unresponsive to other treatments. It binds to nuclear receptors that regulates gene transcription. They induce keratinocyte differentiation and reduce epidermal hyperplasia, leading to the slowing of cell reproduction. Acitretin is readily absorbed and widely distributed after oral administration. A therapeutic effect occurs after two to four weeks or longer.

Patients who have received the medication are advised against giving blood for at least three years due to the risk of birth defects.[7]

Adverse effects

Acitretin is highly teratogenic and noted for the possibility of severe birth defects, such as abnormal development in the face and skull, as well as spinal, hip, forearm, and ear deformations.[8] It should not be used by pregnant women or women planning to get pregnant within 3 years following the use of acitretin. Sexually active women of childbearing age who use acitretin should also use at least two forms of birth control concurrently. Men and women who use it should not donate blood for three years after using it, because of the possibility that the blood might be used in a pregnant patient and cause birth defects.

In addition, it may cause nausea, headache, itching, dry, red or flaky skin, dry or red eyes, dry or chapped lips, swollen lips, dry mouth, thirst, cystic acne or hair loss.[9][4][10]

Pharmacokinetics

Acitretin is a metabolite of etretinate, which was used prior to the introduction of acitretin. Etretinate was discontinued because it had a narrow therapeutic index as well as a long elimination half-life (t1/2 = 120 days), making dosing difficult. In contrast, acitretin's half-life is approximately 2 days. However, because acitretin can be reverse metabolised into etretinate which has an extremely long half-life, women must avoid becoming pregnant for at least three years[11] after discontinuing acitretin. Therefore, acitretin is generally not recommended for women of child-bearing age with a risk of becoming pregnant.[citation needed]

References

Page Template:Reflist/styles.css has no content.

  1. ^ a b NEOTIGASON acitretin 10mg capsule blister pack (52455) Australian Department of Health and Aged Care
  2. ^ Page Module:Citation/CS1/styles.css has no content.Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in português do Brasil). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 15 August 2023.
  3. ^ Page Module:Citation/CS1/styles.css has no content."Soriatane (acitretin) Capsules". dailymed.nlm.nih.gov. Retrieved 30 December 2023.
  4. ^ a b Page Module:Citation/CS1/styles.css has no content."Soriatane Side Effects". Drugs.com. Retrieved 15 August 2015.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Zito PM, Mazzoni T (January 2021). "Acitretin". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 30137855.
  6. ^ Page Module:Citation/CS1/styles.css has no content."LiverTox: Clinical and Research Information on Drug-Induced Liver Injury Acitretin". National Institute of Diabetes and Digestive and Kidney Diseases. 4 November 2020. Retrieved 31 July 2025.
  7. ^ AABB Technical Manual, American Association of Blood Banks
  8. ^ Page Module:Citation/CS1/styles.css has no content."Acitretin Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 1 May 2025.
  9. ^ Page Module:Citation/CS1/styles.css has no content."Soriatane". WebMD. Retrieved 15 August 2015.
  10. ^ Page Module:Citation/CS1/styles.css has no content."Soriatane (Acitretin) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information at RxList". RxList. Archived from the original on 2 December 2013. Retrieved 15 August 2015.
  11. ^ Page Module:Citation/CS1/styles.css has no content."Important Safety Information for SORIATANE". soriatane.com. Archived from the original on 6 May 2018. Retrieved 31 October 2015.

Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Template:Retinoid receptor modulators Template:GlaxoSmithKline Lua error in mw.title.lua at line 404: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').

Retrieved from "https://cosmopedia.co/index.php?title=Acitretin&oldid=743208"